Research study Program year 2020 Source: CMS Open Payments

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients with Moderate to Severe Hidradenitis Suppurativa

Research payments

$12,887,551

830 payments

Through program year 2020, $12,887,551 in research payments was reported against A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients with Moderate to Severe Hidradenitis Suppurativa, across 830 payments, paid by Janssen Research & Development, LLC.

Paid by: Janssen Research & Development, LLC
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2020	Research	$12,887,551	830

Breakdown

Who paid Research payments · program year 2020

Janssen Research & Development, LLC $12,887,551 830 payments

Who received the money Research payments · program year 2020

Revival Rsrch Institute, Llc Organisation paid for research $1,479,956 119 payments
Randall Derm Organisation paid for research $1,403,252 27 payments
Forcare Clinic Rsrch Organisation paid for research $1,400,769 37 payments
Fl Intrntl Medcl Rsrch Organisation paid for research $1,332,462 14 payments
Doral Medcl Rsrch Organisation paid for research $1,048,966 35 payments
Avita Clinic Rsrch Organisation paid for research $585,628 26 payments
Wolverine Clinic Trials Organisation paid for research $569,420 56 payments
Accel Clnc Rsrch Organisation paid for research $463,851 87 payments
Meridian Clinic Rsrch Organisation paid for research $444,189 28 payments
Clnc Trials Of Swla Organisation paid for research $409,070 38 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.